Trial
NCT00452478
Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Shire
Collaborators
—
Condition
Kidney Diseases
Intervention
Lanthanum carbonate
Why stopped
This study was stopped by the sponsor based on a non-safety related corporate decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-05-25